Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (9807)	7/22/1998 12:19:00 AM
From: milton	Read Replies (1) \| Respond to of 14328

Scott Davis Rather than tout our LSAT's, gpa's etc., I would rather the board return to a sharing of info and some real research. For example, isn't it possible that one factor affecting triby is its foreign income sources which are adversely affected by the strong dollar at the moment. Another, aren't the small caps currently out of favor, lagging the general market, despite the good pe's of many of these small caps. Next, what is the actual trailing and forecast pe's on triby. This is what really counts. A lot of inane sniping because the small cap markets are low now doesn't add to this thread. Finally, triby appears to be on a path to growth to a mid cap through strategic acquisitions. A market cap of 50 million (hopefully 100 million) is a desired goal as it makes triby more attractive to institutions. If this requires issuing stock for acquisition, so long as we get a $1 for $1 trade, then I say go for it. Us triby-ites will win in the end.